Search
Danaher Corp
DHRAdd to Watchlist
204.760USD
+4.830+2.42%
Close 08-07 16:00（ET）Quotes delayed by 15 min
144.91BMarket Cap
39.43P/E TTM
More Details of Danaher Corp Company
Danaher Corporation is a global life sciences and diagnostics innovator. The Company operates through three segments: Biotechnology, Life Sciences and Diagnostics. The Biotechnology segment includes the bioprocessing and discovery and medical businesses and offers a broad range of equipment, consumables and services that are primarily used by customers to advance and accelerate the research, development, manufacture and delivery of biological medicines. The Life Sciences segment offers a broad range of instruments, consumables, services and software that are primarily used by customers to study the basic building blocks of life, including deoxyribonucleic acid (DNA) and ribonucleic acid (RNA), nucleic acid, proteins, metabolites and cells. The Diagnostics segment offers clinical instruments, consumables, software and services that hospitals, physicians’ offices, reference laboratories and other critical care settings use to diagnose disease and make treatment decisions.
Danaher Corp Profile
Ticker SymbolDHR
Company nameDanaher Corp
IPO dateJan 16, 2106
CEOBlair (Rainer M)
Number of employees61000
Security typeOrdinary Share
Fiscal year-endJan 16
Address2200 Pennsylvania Ave NW Ste 800W
CityWASHINGTON
Stock exchangeNASDAQ OMX NASDAQ Basic NYSE
CountryUnited States of America
Postal code20037-1701
Phone12028280850
Websitehttps://www.danaher.com/
Ticker SymbolDHR
IPO dateJan 16, 2106
CEOBlair (Rainer M)
Company Executives of Danaher Corp
Name
Name/Position
Position
Shareholding
Change
Mr. Steven M. Rales
Mr. Steven M. Rales
Chairman of the Board
Chairman of the Board
42.74M
+1.17%
Mr. Mitchell P. Rales
Mr. Mitchell P. Rales
Director
Director
33.50M
+1.49%
Mr. Alan G. Spoon, J.D.
Mr. Alan G. Spoon, J.D.
Independent Director
Independent Director
87.56K
+2.99%
Mr. Rainer M. Blair
Mr. Rainer M. Blair
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
87.51K
+46.00%
Mr. John T. Schwieters
Mr. John T. Schwieters
Independent Director
Independent Director
40.96K
-1.41%
Mr. Greg Milosevich
Mr. Greg Milosevich
Executive Vice President
Executive Vice President
24.47K
+62.95%
Dr. Jose-Carlos Gutierrez-Ramos, Ph.D.
Dr. Jose-Carlos Gutierrez-Ramos, Ph.D.
Senior Vice President, Chief Science Officer
Senior Vice President, Chief Science Officer
23.00K
+58.58%
Mr. Brian W. Ellis
Mr. Brian W. Ellis
Senior Vice President
Senior Vice President
22.97K
+1.92%
Dr. Elias A. Zerhouni, M.D.
Dr. Elias A. Zerhouni, M.D.
Independent Director
Independent Director
19.23K
+11.01%
Mr. Daniel A. Raskas, J.D.
Mr. Daniel A. Raskas, J.D.
Senior Vice President - Corporate Development
Senior Vice President - Corporate Development
16.02K
-29.35%
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Steven M. Rales
Mr. Steven M. Rales
Chairman of the Board
Chairman of the Board
42.74M
+1.17%
Mr. Mitchell P. Rales
Mr. Mitchell P. Rales
Director
Director
33.50M
+1.49%
Mr. Alan G. Spoon, J.D.
Mr. Alan G. Spoon, J.D.
Independent Director
Independent Director
87.56K
+2.99%
Mr. Rainer M. Blair
Mr. Rainer M. Blair
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
87.51K
+46.00%
Mr. John T. Schwieters
Mr. John T. Schwieters
Independent Director
Independent Director
40.96K
-1.41%
Mr. Greg Milosevich
Mr. Greg Milosevich
Executive Vice President
Executive Vice President
24.47K
+62.95%
FAQs
Who are the top five shareholders of Danaher Corp?
The top five shareholders of Danaher Corp are: Mr. Steven M. Rales
How many institutions hold shares of Danaher Corp (DHR)?
As of 2026Q1, 3953 institutions hold shares of Danaher Corp, with a combined market value of approximately 594.48M, accounting for 83.99% of the total shares. Compared to 2025Q4, institutional shareholding has increased by -3972448.00.